within Pharmacolibrary.Drugs.ATC.C;

model C03DB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.52,
    Cl             = 3.1666666666666666e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0011,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00265,
    Tlag           = 900
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C03DB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Triamterene is a potassium-sparing diuretic used in the management of edema and hypertension, often in combination with other diuretics such as hydrochlorothiazide. It acts on the distal renal tubules to inhibit sodium reabsorption while conserving potassium. It is approved and widely used clinically.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following a single oral dose.</p><h4>References</h4><ol><li><p>Hoorn, EJ, &amp; Ellison, DH (2017). Diuretic Resistance. <i>American journal of kidney diseases : the official journal of the National Kidney Foundation</i> 69(1) 136–142. DOI:<a href=&quot;https://doi.org/10.1053/j.ajkd.2016.08.027&quot;>10.1053/j.ajkd.2016.08.027</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27814935/&quot;>https://pubmed.ncbi.nlm.nih.gov/27814935</a></p></li><li><p>Mutschler, E, et al., &amp; Völger, KD (1983). Pharmacokinetics of triamterene. <i>Clinical and experimental hypertension. Part A, Theory and practice</i> 5(2) 249–269. DOI:<a href=&quot;https://doi.org/10.3109/10641968309048825&quot;>10.3109/10641968309048825</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6831748/&quot;>https://pubmed.ncbi.nlm.nih.gov/6831748</a></p></li><li><p>Sörgel, F, et al., &amp; Williams, RL (1985). Oral triamterene disposition. <i>Clinical pharmacology and therapeutics</i> 38(3) 306–312. DOI:<a href=&quot;https://doi.org/10.1038/clpt.1985.176&quot;>10.1038/clpt.1985.176</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4028626/&quot;>https://pubmed.ncbi.nlm.nih.gov/4028626</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C03DB02;
